OneAscent Wealth Management LLC Has $281,000 Stock Holdings in STERIS plc (NYSE:STE)

OneAscent Wealth Management LLC reduced its stake in shares of STERIS plc (NYSE:STE) by 52.2% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,366 shares of the medical equipment provider’s stock after selling 1,490 shares during the quarter. OneAscent Wealth Management LLC’s holdings in STERIS were worth $281,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Avalon Trust Co bought a new stake in STERIS during the fourth quarter worth about $30,000. Human Investing LLC bought a new stake in shares of STERIS during the 4th quarter worth approximately $31,000. Anfield Capital Management LLC boosted its position in shares of STERIS by 100.0% during the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock worth $37,000 after acquiring an additional 91 shares in the last quarter. Central Pacific Bank Trust Division increased its stake in STERIS by 65.5% in the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock valued at $39,000 after acquiring an additional 76 shares during the last quarter. Finally, Manchester Capital Management LLC raised its position in STERIS by 182.7% during the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock valued at $44,000 after purchasing an additional 137 shares in the last quarter. 94.69% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

STE has been the topic of a number of research analyst reports. JMP Securities reaffirmed a “market outperform” rating and issued a $265.00 target price on shares of STERIS in a report on Thursday, February 6th. Piper Sandler lifted their target price on STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research report on Monday, February 3rd. Finally, Stephens reissued an “overweight” rating and issued a $240.00 target price on shares of STERIS in a report on Thursday, February 6th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $258.75.

STERIS Stock Down 0.6 %

Shares of NYSE STE opened at $222.99 on Friday. STERIS plc has a 1 year low of $197.82 and a 1 year high of $248.24. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40. The firm has a market cap of $21.91 billion, a PE ratio of 47.34 and a beta of 0.92. The company has a 50 day simple moving average of $222.51 and a 200 day simple moving average of $221.48.

STERIS (NYSE:STE) last issued its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. On average, research analysts forecast that STERIS plc will post 9.08 EPS for the current year.

STERIS Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Thursday, February 20th were paid a $0.57 dividend. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.02%. The ex-dividend date was Thursday, February 20th. STERIS’s dividend payout ratio is currently 48.41%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.